StockVS

Precision Optics Corporation, Inc. (POCI) Aandelenanalyse

Gezondheidszorg

Precision Optics Corporation, Inc.

$4.97

+$0.04 (+0.81%)

Laatst bijgewerkt: 26 mei 2026

Koersverloop

Analyse

Bedrijfsoverzicht

Precision Optics Corporation, Inc. is a specialized manufacturer and distributor focused on the design, development, and production of optical and illumination systems, along with their associated components. The company primarily serves the medical sector in the United States by supplying critical instrumentation products such as endoscopes and endocouplers to healthcare providers. Operating within the Healthcare sector and specifically the Medical Instruments & Supplies industry, the firm caters to entities requiring high-precision diagnostic tools for surgical procedures. As a micro-cap entity, the company holds a market capitalization of $45.57M, generates annual revenue of $24.42M, and maintains a workforce of 90 employees. These valuation and financial scale metrics indicate that Precision Optics is a small-cap player with limited market penetration, suggesting that its operations are confined to a niche segment of the broader medical device market rather than a dominant position.

Financiële gezondheid

The company reported a trailing twelve-month revenue of $24.42M, yet it recorded a net income of -$6,917,139 and an EBITDA of -$6,477,614, revealing a significant gap between top-line sales and bottom-line profitability. This substantial disparity between revenue and net income highlights a highly strained cost structure where operating expenses and cost of goods sold collectively exceed gross revenue by a wide margin. The free cash flow stands at -$706,907, which indicates a negative cash conversion that limits the company's financial flexibility and its ability to fund operations or investments without external capital injection. Analyzing the three primary margins, Precision Optics displays a gross margin of 9.7%, an operating margin of -23.6%, and a profit margin of -28.3%, with the negative operating and profit margins signaling that core business activities are currently unprofitable after accounting for all expenses. On the balance sheet, the company holds $881,486 in cash against total debt of $4.42M, resulting in a debt-to-equity ratio of 47.33% that suggests a leveraged position despite the relatively small absolute debt amount. The current ratio is 1.05, which implies that the company possesses just sufficient current assets to cover its current liabilities, leaving very little buffer against short-term liquidity shocks. Furthermore, the return on equity is -73.6% and the return on assets is -20.8%, metrics that reveal management is currently generating negative returns on the capital invested in the company.

Waarderingsbeoordeling

Valuation metrics for Precision Optics are unavailable in the traditional sense as the trailing P/E ratio and forward P/E are both listed as N/A, implying that the absence of positive earnings prevents the calculation of these standard multiples. Consequently, the market cannot rely on earnings-based valuations to assess the stock, forcing reliance on alternative metrics such as the price-to-book ratio of 3.45, which indicates that the stock trades at a premium of 3.45 times its book value per share. The price-to-sales ratio is 1.87, and the EV/EBITDA is -5.52, suggesting that the market is pricing the company based on its asset base and sales potential rather than current profitability or earnings power. Price action analysis shows the 52-week high at $6.04 and the 52-week low at $3.55, placing the current trading range within a band of volatility where the stock has not yet recovered to its yearly peak. The beta value is 0.33, which indicates that the stock's price volatility is significantly lower than the broader market, suggesting less sensitivity to general market movements compared to large-cap equities.

Growth & Income

Regarding growth trajectories, the company experienced a revenue growth of 62.8% year-over-year, while the earnings growth rate is N/A due to the current lack of positive earnings. Since there are no positive earnings to compare against, the disparity between revenue growth and earnings is not applicable in the traditional sense, but the negative earnings growth implies that despite surging sales, the company is still struggling to achieve profitability. Precision Optics does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning the company reinvests all available cash flow back into its operations and growth initiatives rather than distributing income to shareholders. This reinvestment strategy is typical for small-cap growth companies that prioritize expansion and market share acquisition over shareholder returns. Overall, the growth and income profile of Precision Optics is characterized by rapid revenue expansion coupled with significant losses and a complete absence of dividend income.

Vergelijking met sectorgenoten

Precision Optics Corporation, Inc. (POCI) is actief in de Medische Instrumenten & Benodigdheden-sector. Zo verhoudt het zich tot de naaste sectorgenoten op basis van marktkapitalisatie:

Bedrijf Ticker Marktkapitalisatie K/W-verhouding
Precision Optics Corporation, Inc. POCI $53.96M N/A
Intuitive Surgical, Inc. ISRG $154.64B 53.2
Becton, Dickinson and Company BDX $40.71B 25.8
Alcon Inc. ALC $33.02B 40.5

De gemiddelde K/W-verhouding in de Medische Instrumenten & Benodigdheden-sector is 208.0x. Precision Optics Corporation, Inc. wordt verhandeld tegen een K/W van N/A.

Deze analyse is gegenereerd door AI en dient alleen ter informatie. Het vormt geen financieel advies. Gegevens kunnen vertraagd of onnauwkeurig zijn. Doe altijd je eigen onderzoek en raadpleeg een gekwalificeerde financieel adviseur voordat je beleggingsbeslissingen neemt.

Over Precision Optics Corporation, Inc.

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies for industrial and military use. It markets its products to medical device companies. Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Gardner, Massachusetts.

Bedrijfsbeschrijving wordt in het Engels weergegeven.

Bezoek website →

Belangrijke Cijfers

Marktkapitalisatie
$53.96M
K/W-verhouding
N/A
52-weken hoog
$6.04
52-weken laag
$3.55
Gem. Volume
37.34K

Gegevens verstrekt door Yahoo Finance via yfinance. Dagelijks bijgewerkt.

Bedrijfsinfo

Beurs
NASDAQ
Land
United States
Werknemers
90